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ABSTRAK
Latar belakang: ketoasidosis Diabetes (KAD) adalah komplikasi Diabetes Melitus (DM) yang berpotensi 
mengakibatkan kematian. Saat ini belum ada studi di Indonesia yang membandingkan pengukuran kadar 
beta-hidroksibutirat (β-OHB) kapiler dengan asetoasetat pada urin untuk memonitor respon terapi dari DKA 
pada remaja. Metode: studi prospektif terhadap 37 remaja dan anak dengan diagnosis KAD di Rumah Sakit 
Dr. Cipto Mangunkusumo selama Juni 2006-Maret 2011 hingga KAD dinyatakan resolusi. Pemeriksaan gula 
darah sewaktu, β-OHB kapiler, dan keton urin dilakukan setiap jam, sedangkan analisis gas darah dan elektrolit 
dilakukan setiap empat jam. Hasil: median waktu resolusi KAD adalah 21 (9-52) jam. Saat median resolusi KAD, 
terdapat korelasi signifikan yang lebih baik antara kadar β-OHB kapiler dibandingkan dengan kadar keton urin 
terhadap pH (r= -0,52, p= 0,003 vs r= -0,49, p= 0,005) serta terhadap bikarbonat (r= -0,60, p= 0,000 vs r= 
-0,48, p= 0,007). Kadar β-OHB kapiler seluruhnya menunjukkan hasil negatif saat median resolusi, sedangkan 
ketonuria masih ditemukan hingga 9 jam paska resolusi. Kesimpulan: kadar keton darah menunjukkan korelasi 
yang lebih baik terhadap pH dan bikarbonat untuk menentukan respon terapi KAD pada remaja dan anak bila 
dibandingkan dengan metode keton urin.
Kata kunci: betahidroksibutirat kapiler, ketoasidosis diabetes, keton urin, waktu resolusi.
ABSTRACT
Background: diabetic ketoacidosis (DKA) is a potentially lethal complication of diabetes mellitus (DM). 
There is no study in Indonesia that compares the much-preferred capillary beta hydroxybutirate (β-OHB) 
measurement to urine acetoacetate in monitoring therapeutic response of DKA in adolescents. Methods: a 
prospective study of 37 adolescents and children with DKA in Cipto Mangunkusumo Hospital was done between 
June 2006 and March 2011. The patients were followed until the time of DKA resolution. Hourly measurements of 
random blood glucose, capillary β-OHB concentration, and urine ketones were done, while blood gas analysis and 
electrolyte were measured every four hours. Results: median time to resolution was 21 (9-52) hours. Compared 
to urine ketones, capillary β-OHB concentration showed stronger correlation with pH (r= -0.52, p= 0,003 vs 
r= -0.49, p= 0,005) and bicarbonate level (r=-0.60, p=0.000 vs r= -0.48, p=0.007) during the median time of 
DKA resolution. All capillary β-OHB measurement yielded negative results at median time of DKA resolution, 
while urine ketones were still detected up to 9 hours after resolution. Conclusion: blood ketone concentration 
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showed a better correlation with pH and bicarbonate level, as a tool to monitor therapeutic response in DKA 
in adolescent, compared to traditional urine ketones test in adolescents.
Keywords: capillary betahydroxybutirate, diabetic ketoacidosis, urine ketones, resolution time.
INTRODUCTION
Diabetic ketoacidosis (DKA) is a potentially 
lethal complication of diabetes mellitus (DM).1 
Among young patients with type 1 diabetes 
mellitus (T1DM), DKA is the most common 
cause of mortality and the risk of developing the 
condition ranges around 1-10% per patients per 
year.2,3 A report from the Endocrinology Taskforce 
of Indonesian Pediatric Society from May 2009 
to March 2011 demonstrated that 591 children 
and adolescents were living with T1DM across 
Indonesia. In 2010, Dr. Cipto Mangunkusumo 
hospital recorded 98 cases of DKA over a four-
year period, which resulted in 14 deaths.4
The ur inary  ketone (acetoaceta te) 
measurement is traditionally used in monitoring 
DKA patients. This examination does not 
measure the level of betahydroxybutirate 
(β-OHB) which is the predominant ketone body 
in DKA.5 During the course of DKA treatment, 
there are drastic changes in ratio of acetoacetate 
to β-OHB from the normal 3:1 ratio to 7:1, until 
15:1.6 Besides prone to subjectivity, the urine 
sample collection in young population is often 
difficult, impractical and time consuming.5,7 
There are many factors that lead to high rates of 
false positive and false negative results in urine 
ketone examination.5,8,9
In respect of successful DKA therapy, the 
conversions of β-OHB to acetoacetate take place, 
owing to chains of oxidative reaction in the liver. 
In turn, the level of acetoacetate and acetone 
will rise as the β-OHB concentration falls.10,11 
Motivated by the unreliability of urine ketone 
to assess DKA severity and insulin response, 
the American Diabetes Association (ADA) 
recommends the capillary β-OHB measurement 
in diagnosis and monitoring of DKA.12
This study was the first in Indonesia to 
compare the correlation between capillary 
β-OHB and ketone urine level to the blood gas 
analysis (BGA) parameters, as the standard of 
monitoring DKA therapeutic response.
METHODS
Subjects aged 5-18 years admitted with 
diagnosis of DKA to Cipto Mangunkusumo 
Hospital, Jakarta, were recruited consecutively 
from June 2006 to March 2011. In this study, 
DKA was defined as clinical findings of random 
blood glucose (RBG) >200 mg/dL, pH <7.5 or 
bicarbonate level <15 mEq/L, positive urine 
ketones (concentration >0.5 mmol/L), and 
positive capillary β-OHB (concentration >0.5 
mmol/L).
Patients with hyperglycemia due to other 
causes, diagnosed with respiratory acidosis, and 
whose parents refused to consent were excluded 
from the study. Those who failed to follow 
management protocol or died prior to 36 hours 
after admission were not included in the analysis.
There were 40 episodes of DKA recorded. 
Two patients were excluded of unwillingness to 
participate and one patient who died in the first 
three hours of care was considered as a drop out. 
We followed 37 DKA cases during the period 
of study.
Study Protocol
All patients arrived in the intensive or 
intermediate care were managed according to the 
standard procedure of DKA management in our 
hospital. A prospective analytical study was done 
to all subjects until the time of DKA resolution. 
Basic data were obtained along with informed 
written consent from patients’ legal guardians.
Random blood glucose, capillary β-OHB 
concentration, and urine ketones were measured 
every hour. Capillary β-OHB was measured 
using Medisense Optium®  (Abbott). Required 
blood sample for the electrochemical strip was 
5 μl, and the result was displayed after 30s. This 
system was accurate for β-OHB levels from 0 to 6 
mmol/l and would show high (Hi) value in above 
6 mmol/L. The determination of urine ketones, 
Multistix® (Bayer) was utilized.
Blood gas analysis and electrolytes (sodium, 
potassium and chloride) were measured every 
Aman B. Pulungan                                                                                                                  Acta Med Indones-Indones J Intern Med
48
four hours. We followed the patients until DKA 
resolutions were established (GCS=15, random 
blood glucose ≤200mg/dL and HCO3 ≥15 
mEq/L) or during the first 36 hours since the 
start of observation.
This study protocol was approved by the 
Ethics Committee of Faculty of Medicine, 
University of Indonesia - Cipto Mangunkusumo 
Hospital, Jakarta.
Statistical Analyses
Data were statistically analyzed using SPSS 
17.0 software. Prior to the statistical analyses, 
data sets were tested for normality, to determine 
whether statistical correlations were appropriate. 
RESULTS
Clinical and Metabolic Characteristics of 
Subjects
The clinical and metabolic baseline 
characteristics of the patients are summarized 
in Table 1. Among 37 DKA cases (2 males, 35 
females), the average age was 11.7 (SD 2.81). 
Most subjects were adolescents aged ≥10 years, 
whose proportion compared to children <10 
years old was 30 to 7 (4.28:1). All patients were 
previously diagnosed with T1DM. The median 
time to resolution was 21 (9-52) hours. The 
data distributions of DKA resolution time were 
abnormal, comprised of <21 hours (24/37), 22-
36 hours (4/37), 37-48 hours (8/37), and >48 
hours (1/37).
Marked prior laboratory findings in this study 
(Table 1) included the presence of hyperglycemia 
(473.9 (SD 126.1 mg/dL)), hyperketonemia (4 
(SD 1.1 mmol/L)), and urine ketones (median: 
8 [4-6] mmol/L). Metabolic acidosis observed 
with mean blood pH 7.1 (SD 0.1); base excess 
of -21 (SD 5.2) mmol/L, anion gap of 28.7 (SD 
7.1) mEq/dL, and median HCO3 level of 6.9 
(1.8-16.6) mmol/L. The subjects’ characteristics 
are summarized in Table 1.
Capillary β-OHB and Urinary Ketone Levels 
The median distribution of capillary β-OHB 
and urinary ketone levels decreased with respect 
to therapeutic response as shown in Figures 1 
and 2. Following the median resolution time, 
there were 8 patients with persistent positive 
urine ketone until 9 hours after resolution, while 
β-OHB levels in all subjects were already within 
normal range.
There was no correlation between both 
capillary β-OHB level and urine ketones level to 
BGA parameters during early hours of treatment. 
At the median time of DKA resolution (i.e. in the 
21st hour of monitoring), moderate significant 
correlations between urine ketones level and 
blood pH (r=0.49, p=0.005), HCO3 (r=-0.48, 
p=0.007), and anion gap (r=0.57, p=0.001) 
were found. On the other hand, moderate trends 
toward significant correlations were also found 
between capillary β-OHB level and blood pH 
(r= -0.52 and p=0.003) as well as HCO3 (r= 
-0.60, p=0.000). However, capillary β-OHB level 
correlated weakly to anion gap during resolution 
(r=0.37, p=0.04). The comparison between 
correlations of urine ketones and β-OHB level 
to blood gas analysis parameters is presented in 
Table 2.
Table 1. Clinical and metabolic characteristics of subjects
Variables Values (N=37)
Sex ratio (male: female) 1 : 17.5
Age (years) 11.7 (2.81)#
Age group ratio (adolescents : 
children) 4.28 : 1
Time to resolution (hours) 21 (9-52)*
Duration of insulin infusion 
(hours) 28 (9-60)*
Random blood glucose (mg/dL) 473.9 (126.1)#
β-OHB (mmol/L) 4 (1.1)#
Urine ketones (mmol/L) 8 (4-16)*
Urea (mg/dL) 34 (10-72)*
BUN (mg/dL) 15.8 (4.64-33.4)*




Blood pH 7.1 (0.1)#
PCO2 (mmHg) 18.5 (5.2)#
PaO2 (mmHg) 113.6 (33.1)#
SaO2 (%) 93.2 (7.2)#
BE (mmol/L) -21.9 (5.2)#
HCO3 (mmol/L) 6.9 (1.8-16.6)*
Sodium (mEq/dL) 136.8 (5.4)#
Potassium (mEq/dL) 4.8 (0.9)#
Chloride (mEq/dL) 101.1 (5.6)#
Anion gap (mEq/dL) 28.7 (7.1)#
* Median (range); #  Mean (SD)
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Figure 1. Trend on median value of capillary b-OHB relative 
to time of measurement.
Figure 2. Trend on median value of urine ketones relative to 
time of measurement.
Table 2. Correlation between urine ketones level and capillary β-OHB level to blood gas analysis parameters
Variables Correlation 
coefficient
P value Correlation formula
pH at the first hour
 - urine ketones r = -0.14 0.407
 - capillary β-OHB r = -0.18 0.292
pH at the 21st hour (median time of DKA resolution)
 - urine ketones r = -0.49 0.005 pH= 7.38+(-0.01) urine ketones 
 - capillary β-OHB r = -0.52 0.003 pH= 7.39+(0.04) β-OHB
HCO3 at the first hour
 - urine ketones r = -0.04 0.832
 - capillary β-OHB r = -0.15 0.374
HCO3 at the 21st hour (median time of DKA resolution)
 - urine ketones r = -0.48 0.007 HCO3=16.16+(-0.57) urine ketones
 - capillary β-OHB r = -0.60 0.000 HCO3=17.31+(-2.37) β-OHB
Anion gap at the first hour 
 - urine ketones r = 0.15 0.363
 - capillary β-OHB r = 0.06 0.708
Anion gap at the 21st hour (median time of DKA resolution)
 - urine ketones r = 0.57 0.001 AG=11.57+(1.29) urine ketones 
 - capillary β-OHB r = 0.37 0.04 AG= 12.82+(2.77) β-OHB
There were moderate significant correlations 
between capillary β-OHB level and urine ketones 
at the beginning of monitoring time (r=0.51, 
p=0.001) and during the median time of DKA 
resolution (r=0.58, p=0.000), as described in 
Table 3.
DISCUSSION
In this study, we found that DKA episodes 
were more frequent in female patients, with ratio 
of 1: 17.5 (male : female). Rewers et al3 reported 
no difference in the ratio of DKA incidence 
between sexes. The difference in this particular 
study might be attributed to higher number of 
female patients with recurrent DKA episodes, 
Table 3. Correlation between capillary β-OHB level and 
urine ketones
Blood ketones Correlation 
coefficient 
Correlation formula 
for capillary β-OHB 
and urine ketones
Blood ketones at 
the first hour
r = 0.51, 
p=0.001
β-OHB = 3.22 + (2.08) 
urine ketones
Blood ketones at 
the 21st hour
r = 0.58, 
p=0.000
β-OHB = 1.34 + (1.86) 
urine ketones
in accordance to a previous study stating that 
recurrent DKA affects more female than male 
population.13
Most patients were in the adolescent age 
category (≥10-year-old). Similarly, a prior study 
mentioned that the risk of DKA increased in age 
Aman B. Pulungan                                                                                                                  Acta Med Indones-Indones J Intern Med
50
Later in the course of our study, around the 
median time of DKA resolution, significant 
correlations were observed. The correlation 
of β-OHB to pH is stronger than correlation 
between urine ketones and pH (r=-0.52, p=0.003 
vs. r=-0.49, p=0.04). The correlation between 
β-OHB and HCO3 was also stronger compared 
to the correlation between urine ketones and 
HCO3 (r=-0.60, p=0.000 vs. r=-0.48, p=0.007). 
Conversely, better correlation between urine 
ketones and anion gap was demonstrated in 
comparison with β-OHB and anion gap (r=0.57, 
p=0.001 vs. r=0.37, p=0.04). 
Strong correlations between β-OHB level 
and pH following therapeutic response were 
reported by Turan et al21 (r=-0.41, p<0.05), Ham 
et al19 (r=-0.61, p<0.0001), Vanelli et al7 (r=-0.82, 
p<0.001), and Rewers et al2 (r=-0.63, p<0.0001). 
Significant correlation between β-OHB and 
HCO3 were also reported by Turan et al21 (r= 
-0.35, p<0.05), Vanelli et al7 (r= -0.63, p=0.001), 
and Rewers et al13 (r= -0.74, p<0.0001). Positive 
correlation between capillary β-OHB level and 
anion gap was reported by Naunheim et al19 
(r=0.66, p<0.001).
The assessments of metabolic parameters 
that belong to independent variables in the 
change of acid-base balance such as lactate, 
serum albumin, and electrolytes such as calcium, 
magnesium, and phosphate were not done.22 The 
pH and bicarbonate were dependent variables in 
Stewart’s acid-base balance approach, and highly 
influenced by the many independent variables.23 
Both β-OHB and ketone urine showed lack 
of correlations to pH, proving that pH was 
not specific to DKA. Shift in anion gap are 
correlated with immeasurable cations, protein, 
and phosphate. Increase in organic acid is also 
inconsistent with the rise in anion gap.  71% 
patients with elevated lactate concentration had 
normal anion gap. This makes anion gap neither 
sensitive nor specific to acidosis.24 Despite 
the low the sensitivities and specificities, the 
selection of pH, bicarbonate and anion gap as 
determinants in our study was based on standard 
criteria released by International Society for 
Pediatric and Adolescent Diabetes Clinical 
Practice (ISPAD).2 
We observed a significant correlations 
5 to 9 years and 10 to 14 years.3 Higher insulin 
requirement in early pubertal age is explained by 
the increasing activities of sex steroids hormones 
and growth hormones, which both have anti-
insulin effects.14
The median time of DKA resolution in this 
study was 21 hours (9-52). DKA resolved in 
abnormal distributions, with less than 21 hours 
(24/37), 22 - 36 hours (4 /37), 37-48 hours (8/37), 
and >48 hours (1/37). One subject, which DKA 
was resolved in more than 48 hours had infection 
and cerebral edema.
According to Umpierrez et al15, the mean 
time to resolution was 16 (SD 2) hours. Mrozik 
et al16 presented DKA resolution with the median 
time to resolution based on BGA parameters 
(defined as the median time to reach pH>7.3) 
at 14.2 (8.6-20.1) hours, HCO3 >15 mmol/L at 
12.9 (8.6-20) hours and anion gap <16.1 at 10.7 
(8.2-15) hours. The study observed delayed 
improvement of acidosis in 50% of subjects 
related to hyperchloremic acidosis, related 
to loss of bicarbonate or due to iatrogenic 
effects of NaCl infusion.16 Another report of 
hyperchloremia incidence (indicated by the ratio 
of plasma chloride to natrium of more than 0.79) 
increased from 6% to 94%, from early to 20 
hours after treatment initiation, respectively. The 
occurrence of hyperchloremic acidosis might 
influence the time of DKA resolution. However, 
the correlation was not tested in this study. 
To minimize the incidence of hyperchloremic 
acidosis, a careful calculation in regards to 
the amount of resuscitation fluid was applied 
according to the ISPAD consensus.
During the initial period of monitoring, there 
was no correlation between both capillary β-OHB 
level and urine ketone to BGA parameters. 
This finding is consistent with prior studies 
held by Vanelli et al7 and Tantiwong et al.10 
Studies regarding correlation between β-OHB 
and BGA parameters at the time of diagnosis 
yielded different outcomes. Ham et al18 showed 
a significant correlation between β-OHB and 
pH (r= -0.62, p<0.0001). Similarly, Naunheim19 
found a significant correlation between β-OHB 
level and anion gap (r= 0.66, p<0.001), while 
Ali et al20 stated that β-OHB was significantly 
correlated with HCO3 level (r= 0.68, p<0.001).
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between β-OHB level and urine ketones in early 
monitoring period (r= 0.51, p= 0.001) and at 
the median time of DKA resolution (r= 0.58, 
p=0,000). A positive correlation between β-OHB 
level and urine ketones later in monitoring was 
previously seen 7.8 (SD 2) hours post-therapy; 
r=0.8, p<0.05), but not in few first hours (3.3 (SD 
1.4) hours post-therapy).21 Prior studies found 
positive correlations between β-OHB level and 
urine ketones only at low level.5,25
Significant correlation between β-OHB and 
urine ketone throughout this study showed that 
β-OHB is equal, if not better, in monitoring 
DKA therapy response. Periodic examination of 
capillary β-OHB level was superior compared 
to urine ketone. Negative capillary β-OHB 
level (≤0.5 mmol/L) was found in all research 
subjects by the time of resolution, while 8 
subjects remained urinary ketone-positive until 
9 hours post DKA resolution. This result is 
aligned with studies conducted by Umpierrez 
et al15 and Guerci et al11. Positive urine ketone 
after resolution of DKA caused by conversion 
of β-OHB to acetoacetate and the increased 
hepatocyte oxidative reaction resulted in rise of 
urinary ketones and acetone levels, along with 
diminution of capillary β-OHB concentration. 
The urine ketone test may depict a false picture of 
ketosis, leading to administration of unrequired 
high dose of insulin that might be harmful for 
the patients.7
CONCLUSION
Capillary β-OHB elucidated better correlation 
to pH and bicarbonate when compared to urine 
ketones upon DKA resolution. A significant 
correlation between capillary β-OHB and urine 
ketones suggests that the measurement of blood 
ketone level may be a replacement for urine 
ketones examination in monitoring therapeutic 
response of DKA in children and adolescents.
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